Plenary Lecture 2
Spotlight Session 2, 3
Sponsored Seminar
Bristol Myers Squibb
Co-sponsored Luncheon Seminar 1
- Day:
- THURSDAY・MAY23
- Time:
- 12:30-13:30
- Venue:
- Room 1 (Hall C)
A Focused Approach: Targeting Muscarinic Receptors in Schizophrenia
Speaker
Prakash Masand
Duke-NUS Academic Medicine Education Institute
Speaker
Ken Kramer
Medical Affairs, NeuroPsychiatry Bristol Myers Squibb
Otsuka Pharmaceutical Co., Ltd.
Co-sponsored Symposium 1
- Day:
- THURSDAY・MAY23
- Time:
- 15:45-17:45
- Venue:
- Room 1 (Hall C)
To Achieve Personal Goals for Patients with Schizophrenia in Patient Centered Care
Chair
Koichiro Watanabe
Department of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan
Chair
Nakao Iwata
Department of Psychiatry, Fujita Health University School of Medicine, Aichi, Japan
Speaker
Christoph U Correll
Psychiatry and Molecular Medicine Zucker School of Medicine at Hofstra / Northwell, New York, USA / Department of Child and Adolescent Psychiatry Charité University Medicine, Berlin, Germany
The Significance of Personal Goals in Schizophrenia Treatment: Unmet Needs, Therapeutic Approaches, and Recovery Strategies
Speaker
Hiroyoshi Takeuchi
Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan
Optimizing Antipsychotic Treatment for Relapse Prevention and Clinical Recovery in Schizophrenia
Speaker
Naoki Hashimoto
Department of Psychiatry, Hokkaido University Graduate School of Medicine, Hokkaido, Japan
Psychosocial Treatment with a Focus on Recovery
Otsuka Pharmaceutical Development & Commercialization, Inc.
Co-sponsored Morning Seminar 1
- Day:
- FRIDAY・MAY24
- Time:
- 8:15-9:15
- Venue:
- Room 2 (Hall B7(1))
Understanding Neuroplasticity in the Treatment of Depression and the Potential Role of Digital Therapeutics
Chair
Atsuo Nakagawa
St. Marianna University School of Medicine
Speaker
Atsuo Nakagawa
St. Marianna University School of Medicine
Speaker
Craig Chepke
Excel Psychiatric Associates
Japanese Session
Takeda Pharmaceutical Company Limited, Japan Medical Office/Lundbeck Japan K.K., Medical AffairsCo-sponsored Symposium 2
- Day:
- FRIDAY・MAY24
- Time:
- 10:45-12:00
- Venue:
- Room 12 (Hall D5)
Strategic Approaches to Achieve Recovery
Chair
Hiroyuki Uchida
Department of Neuropsychiatry, Keio University School of Medicine
Speaker
Yoshikazu Takaesu
Department of Neuropsychiatry, Graduate School of Medicine, University of the Ryukyus
Measurement-Based Care in Major Depressive Disorder ~From Remission to Functional Recovery~
Speaker
Takashi Tsuboi
Department of Neuropsychiatry, Kyorin University School of Medicine
Challenges to Treatment and Assessment for Achieving Personal Recovery in Patients with Major Depressive Disorder
Boehringer Ingelheim International GmbH
Co-sponsored Symposium 3
- Day:
- FRIDAY・MAY24
- Time:
- 15:00-16:00
- Venue:
- Room 2 (Hall B7(1))
Cognitive Impairment is a Core Feature of Schizophrenia
Chair
Philip Harvey
Psychiatry and Behavioral Sciences at the University of Miami Miller School of Medicine
Chair
Kazuyuki Nakagome
National Center of Neurology and Psychiatry
Speaker
Kazuyuki Nakagome
National Center of Neurology and Psychiatry
Cognitive Impairment Associated With Schizophrenia (CIAS) in Japan: Perception and Evaluation
Speaker
Richard Keefe
Duke University School of Medicine, Durham, NC, USA
Perception and Evaluation of CIAS Beyond Japan
Speaker
Philip Harvey
Professor of Psychiatry and Behavioral Sciences at the University of Miami Miller School of Medicine
How Deficits in Neural Plasticity and Network Function Give Rise to Cognitive Impairment
Progressive Policy Institute
Co-sponsored Symposium 4
- Day:
- FRIDAY・MAY24
- Time:
- 17:00-19:00
- Venue:
- Room 16 (G502)
Tobacco Harm Reduction - an Update
Chair
Raymond S Niaura
New York University
Chair
Kohji Takada
Department of Psyshiatry, Jikei University School of Medicine/Department of Psychology, Teikyo University
Discussant
Naoyuki Hironaka
Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science
Speaker
Katarzyna Kinga Kowalczyk
Global Public Health Network
Harm reduction – origins, successes and untapped potential
Speaker
Jindrich Voboril
Office of the Government Envoy for Addiction Policies, Czech Republic
The EU Debate: Harm Reduction as a policy approach – a challenge to abstinence focused policies
Speaker
David MacKintosh
Knowledge•Action•Change
Smoking, safer nicotine products and tobacco harm reduction ―around the world in fifteen minutes
Speaker
David T Sweanor
Centre for Health Law, Policy & Ethics, University of Ottawa,/ Faculty of Law, University of Ottawa, /Global Leadership Council, Boston University School of Public Health
Japan tops the world in reducing cigarette sales
Speaker
Raymond S Niaura
Departments of Social and Behavioral Sciences, Epidemiology/Department of Epidemiology, School of Global Public Health New York University
Can e-cigarettes help tobacco cigarette smokers quit? A review of the evidence
Speaker
Yutaka Kosaki
Department of Psychology, Waseda University
Decision-making and habit: understanding maladaptive behaviour from basic animal learning research
Takeda Pharmaceutical Company Limited/Lundbeck Japan K.K.
Co-sponsored Luncheon Seminar 2
- Day:
- FRIDAY・MAY24
- Time:
- 12:15-13:15
- Venue:
- Room 2 (Hall B7(1))
Current Challenges and Implications of Cognitive Performance for Clinical Practice in the Treatment of Major Depressive Disorder
Chair
Hikaru Hori
Faculty of medicine, Department of psychiatry, Fukuoka University
Speaker
Bernhard Baune
Department of Psychiatry, University of Münster, Germany
Viatris Pharmaceuticals Japan Inc.
Co-sponsored Luncheon Seminar 3
- Day:
- FRIDAY・MAY24
- Time:
- 12:15-13:15
- Venue:
- Room 4 (Hall D1)
Potential targets for the treatment of depression: The inflammatory hypothesis.
Chair
Hiroyuki Uchida
Department of Neuropsychiatry, Keio University School of Medicine
Speaker
Masaaki Iwata
Department of Neuropsychiatry, Brain and Neurosciences, Faculty of Medicine Tottori university
Japanese Session
Otsuka Pharmaceutical Co, Ltd.Co-sponsored Luncheon Seminar 4
- Day:
- FRIDAY・MAY24
- Time:
- 12:15-13:15
- Venue:
- Room 12 (Hall D5)
How to proceed in the management of treat resistant depression
-The Possibility of Rexulti-
Chair
Ken Inada
Kitasato University
Speaker
Masaki Kato
Kansai Medical University
Japanese Session
Mitsubishi Tanabe Pharma Corporation/Janssen Pharmaceutical K.K.Co-sponsored Luncheon Seminar 5
- Day:
- FRIDAY・MAY24
- Time:
- 12:15-13:15
- Venue:
- Room 13 (G701)
An update on current understanding of tardive dyskinesia:
epidemiology, pathology, and burden of patients
Chair
Masaomi Iyo
International University of Health and Welfare Graduate School
Speaker
Takahiro A. Kato
Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University
Why was tardive dyskinesia turned a blind eye in psychiatric clinical practice? Learning how to face with patients with tardive dyskinesia from national and international database studies
Speaker
Hiroyoshi Takeuchi
Department of Neuropsychiatry, Keio University School of Medicine
Impact of Tardive Dyskinesia on Daily Life
Japanese Session
Sumitomo Pharma Co., Ltd.Co-sponsored Luncheon Seminar 6
- Day:
- FRIDAY・MAY24
- Time:
- 12:15-13:15
- Venue:
- Room 14 (G602)
Rethinking medication for schizophrenia
Chair
Kotaro Hatta
Department of Psychiatry, Juntendo University Nerima Hospital
Speaker
Amane Tateno
Department of Neuropsychiatry, Graduate School of Medicine, Nippon Medical School
The pharmacotherapy of schizophrenia based on the PET studies
Speaker
Takefumi Suzuki
Department of Neuropsychiatry, University of Yamanashi Faculty of Medicine
User friendly psychopharmacotherapy for schizophrenia : Potential role of transdermal antipsychotics
Japanese Session
Mochida Pharmaceutical Co., Ltd.Co-sponsored Luncheon Seminar 7
- Day:
- FRIDAY・MAY24
- Time:
- 12:15-13:15
- Venue:
- Room 15 (G610)
Perspective of digital biomarkers in mood disorders
Chair
Taishiro Kishimoto
Hills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine
Speaker
Yoshikazu Takaesu
Department of Neuropsychiatry Graduate Shcool of Medicine University of the Ryukyusol of Medicine University of the Ryukyus
Japanese Session
Shionogi & CO.,Ltd.Co-sponsored Luncheon Seminar 8
- Day:
- FRIDAY・MAY24
- Time:
- 12:15-13:15
- Venue:
- Room 16 (G502)
The New Frontier in Pharmacotherapy for Depression:
Moving Beyond the Monoamine Hypothesis
Chair
Yukio Ago
Department of Cellular and Molecular Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University
Speaker
Hitoshi Sakurai
Department of Neuropsychiatry, Kyorin University Faculty of Medicine
The New Frontier in Pharmacotherapy for Depression: Moving Beyond the Monoamine Hypothesis
Japan Agency for Medical Research and Development (AMED)
Co-sponsored Morning Seminar 2
- Day:
- SATURDAY・MAY25
- Time:
- 8:00-9:00
- Venue:
- Room 3 (Hall D7)
Future Brain Science Research in Japan
Chair
Ryosuke Takahashi
Kyoto University
Chair
Tetsushi Kagawa
Japan Agency for Medical Research and Development (AMED)
Speaker
Tomomi Shimogori
RIKEN CBS
Future Brain Science Research in Japan - Perspective from the Core Organization of AMED Brain/MINDS 2.0
Sumitomo Pharma Co., Ltd. Medical Science
Co-sponsored Symposium 5
- Day:
- SATURDAY・MAY25
- Time:
- 14:30-15:30
- Venue:
- Room 1 (Hall C)
Which interventions are key to change the trajectory of schizophrenia?
Chair
Hiroyuki Uchida
Department of Neuropsychiatry School of Medicine, Keio University
Speaker
W. Wolfgang Fleischhacker
Medical University Innsbruck
The relevance of non-psyachotic symptoms in the management of schizophrenia
Japanese Session
Otsuka Pharmaceutical Co., Ltd. Medical AffairsCo-sponsored Symposium 6
- Day:
- SATURDAY・MAY25
- Time:
- 15:50-17:50
- Venue:
- Room 14 (G602)
Measurement Based Care in depression
Chair
Masaki Kato
Department of Neuropsychiatry, Kansai Medical University
Chair
Koichiro Watanabe
Department of Neuropsychiatry, Kyorin University School of Medicine
Speaker
Toshiaki Kikuchi
Keio University School of Medicine, Department of Neuropsychiatry
Measurement Based Care in the Treatment of Depression: Psychotherapeutic Approach to Personal Recovery
Speaker
Hikaru Hori
Department of Psychiatry, Faculty of Medicine, Fukuoka University
Evaluation of workers with depression at the time of return to work
Speaker
Seiji Hongo
Ichigaya Himorogi Clinic, Nanko Kokoro no Clinic
About the real Measurement Based Care using IT devices at psychiatric clinic with using the H-SDS & H-SAS
Japanese Session
Smoking Research Foundation Co-sponsored Symposium 7
*No Snack Distribution
- Day:
- SATURDAY・MAY25
- Time:
- 15:50-17:50
- Venue:
- Room 15 (G610)
Toward a disease concept integrating substance dependence and behavioral addiction: Consideration of common background from basic and clinical perspectives
Chair
Hisatsugu Miyata
Department of Psychiatry, Jikei University School of Medicine/Hirakawa Hospital
Chair
Naoyuki Hironaka
Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science
Speaker
Masabumi Minami
Department of Pharmacology, Faculty of Pharmaceutical Sciences, Hokkaido University
Development of an animal model to analyze neural mechanisms of behavioral addiction
Speaker
Soichiro Ide
Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science
Analysis of addiction using dopamine-related gene-altered mice
Speaker
Atsumi Nitta
Department of Pharmaceutical Therapy & Neuropharmacology, Faculty of Pharmaceutical Sciences, University of Toyama
Role of basolateral amygdala in formation of preference to nicotine intake behavior
Speaker
Kohji Takada
Department of Psychology, Teikyo University/Department of Psyshiatry, Jikei University School of Medicine
Smoking Behaviors: Factors and Mechanisms Mediating Transition to Addiction
Speaker
Hisatsugu Miyata
Department of Psychiatry, Jikei University School of Medicine/Hirakawa Hospital
An attempt to create new diagnostic criteria integrating substance dependence and behavioral addiction
Eisai Co., Ltd./Biogen Japan Ltd.
Co-sponsored Luncheon Seminar 9
- Day:
- SATURDAY・MAY25
- Time:
- 11:40-12:40
- Venue:
- Room 1 (Hall C)
Disease modifying therapies of Alzheimer's disease
Chair
Atsushi Iwata
Tokyo Metropolitan Institute for Geriatrics and Gerontology
Speaker
Takeshi Iwatsubo
Department of Neuropathology, Graduate School of Medicine, The University of Tokyo National Institute of Neuroscience, National Center of Neurology and Psychiatry
Disease modifying therapies of Alzheimer's disease
H. Lundbeck A/S
Co-sponsored Luncheon Seminar 10
- Day:
- SATURDAY・MAY25
- Time:
- 11:40-13:00
- Venue:
- Room 2 (Hall B7(1))
Challenges and Management of MDD in Working population and Elderly Patients
Chair
Masaki Kato
Department of Neuropsychiatry, Kansai Medical University,Japan
Speaker
Toshiaki Kikuchi
Department of Neuropsychiatry, Keio University, Japan
What is the optimal way to manage MDD in working individuals?
Speaker
Michael MC Wong
Department of Psychiatry, The University of Hong Kong, Hong Kong SAR
What can we learn from patient perspectives to improve our approach to treating emotional blunting in MDD?
Speaker
Dong Woo Kang
Department of Psychiatry, The Catholic University of Korea, Seoul St. Mary’s hospital , Republic of Korea
How can we best manage MDD in elderly patients with comorbidities?
Japanese Session
Takeda Pharmaceutical Company Limited.Co-sponsored Luncheon Seminar 11
- Day:
- SATURDAY・MAY25
- Time:
- 11:40-12:40
- Venue:
- Room 12 (Hall D5)
Master of Guanfacine
-Towards ADHD Treatment Based on Brain Pathophysiology-
Chair
Takashi Tsuboi
Department of Neuropsychiatry, Kyorin University School of Medicine
Speaker
Yasuto Kunii
Department of Disaster Psychiatry, International Research Institute of Disaster Science, Tohoku University
Master of Guanfacine -Towards ADHD Treatment Based on Brain Pathophysiology-
Japanese Session
Ono Pharmaceutical Co., Ltd.Co-sponsored Luncheon Seminar 12
- Day:
- SATURDAY・MAY25
- Time:
- 11:40-12:40
- Venue:
- Room 13 (G701)
Parkinson’s disease :The approaches to disease modification
Chair
Nobutaka Hattori
Department of Neurology, Juntendo University Faculty of Medicine
Speaker
Kenjiro Ono
Department of Neurology, Kanazawa University Graduate School of Medical Sciences
Japanese Session
Viatris Pharmaceuticals Japan Inc. Medical AffairsCo-sponsored Luncheon Seminar 13
- Day:
- SATURDAY・MAY25
- Time:
- 11:40-12:40
- Venue:
- Room 14 (G602)
Treatment strategy for major depressive disorder focusing on anxiety symptoms
Chair
Tempei Otsubo
Department of Psychiatry, Tokyo Women's Medical University Adachi Medical Center
Speaker
Yoshikazu Takaesu
Department of Neuropsychiatry, Graduate School of Medicine, University of the Ryukyus
Japanese Session
Sumitomo Pharma Co., Ltd.Co-sponsored Luncheon Seminar 14
- Day:
- SATURDAY・MAY25
- Time:
- 11:40-12:40
- Venue:
- Room 15 (G610)
Future Challenges for Psychiatric Pharmacotherapy
Chair
Nakao Iwata
Department of Psychiatry, Fujita Health University School of Medicine
Speaker
Ichiro Kusumi
Tomakomai Midorigaoka Hospital
Future Challenges for Psychiatric Pharmacotherapy
Japanese Session
Meiji Seika Pharma Co., Ltd.Co-sponsored Luncheon Seminar 15
- Day:
- SATURDAY・MAY25
- Time:
- 11:40-12:40
- Venue:
- Room 16 (G502)
Toward Better Clinical Use of Asenapine - An Overview of the Evidence for Asenapine -
Chair
Ken Inada
Department of Psychiatry, Kitasato University School of Medicine
Speaker
Yoshiteru Takekita
Department of Neuropsychiatry, Kansai Medical University
Japanese Session
Janssen Pharmaceutical K.K.Co-sponsored Luncheon Seminar 16
- Day:
- SATURDAY・MAY25
- Time:
- 11:40-12:40
- Venue:
- Room 17 (G510)
Evidence and prospect for practice of LAI
Chair
Itaru Miura
Fukushima Medical University
Speaker
Fuminari Misawa
Yamanashi Prefectural Kita Hospital
Eisai Co., Ltd./Biogen Japan Ltd.
Co-sponsored Morning Seminar 3
- Day:
- SUNDAY・MAY26
- Time:
- 8:15-9:15
- Venue:
- Room 2 (Hall B7(1))
Reconsidering therapies based on amyloid pathogenesis of Alzheimer's disease
Chair
Takeshi Iwatsubo
Department of Neuropathology, Graduate School of Medicine, The University of Tokyo National Institute of Neuroscience, National Center of Neurology and Psychiatry
Speaker
Kenjiro Ono
Department of Neurology, Kanazawa University Graduate School of Medical Sciences
Japanese Session
Medicine Division, Nippon Boehringer Ingelheim Co., Ltd.Co-sponsored Symposium 8
- Day:
- SUNDAY・MAY26
- Time:
- 14:20-15:50
- Venue:
- Room 12 (Hall D5)
The unmet needs of schizophrenia from various stakeholders' point of view
Chair
Takahiro Nemoto
Department of Neuropsychiatry, Toho University Faculty of Medicine
Chair
Satoru Ikezawa
International University of Health and Welfare, IUHW Mita Hospital
Speaker
Yuhei Yamada
Porque, the Organization of Persons with Psychosocial Disabilities
Interview to the patient with schizophrenia
Speaker
Daisuke Haga
Job training institution ONE MORE TOYONAKA/SENRICHUO
Issues for the recovery of patients with schizophrenia ~Employment support facility's point of view~
Speaker
Kumiko Okada
The National Federation of Associations of Families with The Mental Illness in Japan
Interview to the family of the patient with schizophrenia
Speaker
Hikaru Hori
Department of Psychiatry, Faculty of Medicine, Fukuoka University
After overcoming the acute phase of schizophrenia ~Psychitrist's point of view~
Janssen Asia Pacific
Co-sponsored Symposium 9
- Day:
- SUNDAY・MAY26
- Time:
- 14:50-15:50
- Venue:
- Room 1 (Hall C)
The importance of personalizing long-acting injectables and shared decision-making in schizophrenia
Chair
Norio Furukori
Dokkyo Medical University, Department of Psychiatry
Speaker
John M. Kane
The Zucker Hillside Hospital, Psychiatry Research, Northwell Health
Mitsubishi Tanabe Pharma Corporation/
Janssen Pharmaceutical K.K.
Co-sponsored Luncheon Seminar 17
- Day:
- SUNDAY・MAY26
- Time:
- 12:15-13:15
- Venue:
- Room 1 (Hall C)
State-of-the-art strategies for diagnosing and treating tardive dyskinesia
Chair
Takefumi Suzuki
Department of Neuropsychiatry, University of Yamanashi Faculty of Medicine, Yamanashi
Speaker
John M. Kane
The Zucker Hillside Hospital, Psychiatry Research, Northwell Health
Japanese Session
Sumitomo Pharma Co., Ltd. Medical ScienceCo-sponsored Luncheon Seminar 18
- Day:
- SUNDAY・MAY26
- Time:
- 12:15-13:15
- Venue:
- Room 12 (Hall D5)
Treatment to cognitive dysfunction in schizophrenia
Chair
Ken Inada
Department of Psychiatry, Kitasato University School of Medicine
Speaker
Hikaru Hori
Department of Psychiatry, Faculty of Medicine, Fukuoka University
Treatment to cognitive dysfunction in schizophrenia
Japanese Session
Eisai Co., Ltd.Co-sponsored Luncheon Seminar 19
- Day:
- SUNDAY・MAY26
- Time:
- 12:15-13:15
- Venue:
- Room 13 (G701)
Coping with Sleep Disorders: Significance to the Mind, Brain, and Body
Chair
Yoshikazu Takaesu
Department of Neuropsychiatry, Graduate School of Medicine, University of the Ryukyus
Speaker
Norio Ozaki
Pathophysiology of Mental Disorders, Nagoya University Graduate School of Medicine
Japanese Session
MSD K.K.Co-sponsored Luncheon Seminar 20
- Day:
- SUNDAY・MAY26
- Time:
- 12:15-13:15
- Venue:
- Room 14 (G602)
The Current Status of Hypnotic Prescribing in Japan, Future Challenges and Prospects
Chair
Hitoshi Sakurai
Department of Neuropsychiatry, Kyorin University Faculty of Medicine
Speaker
Masahiro Takeshima
Department of Neuropsychiatry Akita University Graduate School of Medicine
